GlaxoSmithKline plc (GSK) |
|
41.18 0.28 (0.68%)
|
07-16 16:02 |
|
Open: |
41.49 |
Pre. Close: |
40.9 |
|
High:
|
41.49 |
Low:
|
41.09 |
|
Volume:
|
2,796,598 |
Market Cap:
|
103450M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
41.191 - 41.394 |
41.394 - 41.599 |
|
Low:
|
40.286 - 40.499 |
40.499 - 40.716 |
|
Close:
|
40.561 - 40.895 |
40.895 - 41.234 |
|
Technical analysis |
as of: 2019-07-16 3:21:16 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 48.46 One year: 56.60 |
| Support: |
Support1: 40.43 Support2: 39.77 |
| Resistance: |
Resistance1: 41.49 Resistance2: 48.46 |
| Pivot: |
40.67 |
| Moving Average: |
MA(5): 40.90 MA(20): 40.63
MA(100): 40.36 MA(250): 40.03 |
| MACD: |
MACD(12,26): 0.26 Signal(9): 0.24 |
| Stochastic oscillator: |
%K(14,3): 61.62 %D(3): 61.32  |
| RSI: |
RSI(14): 57.76 |
| 52-week: |
High: 42.32 Low: 36.41 Change(%): |
| Average Vol(K): |
3-Month: 239563 10-Days: 265191 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.GSK has closed below upper band by 20.0%. Bollinger Bands are 12% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 15 Jul 2019 15:19:06 Z
Gilead-Galapagos Ink $5.1B Deal for Additional Compounds
Thu, 11 Jul 2019 00:10:56 Z
Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill
Tue, 09 Jul 2019 16:12:47 Z
Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status
Fri, 05 Jul 2019 20:15:12 Z
Health Care Sector Update for 07/05/2019: TYME,ACER,MOR,GSK,CYTX
Fri, 05 Jul 2019 18:15:24 Z
Health Care Sector Update for 07/05/2019: ACER,MOR,GSK,CYTX
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2490.00 |
| Shares Float (M) |
2440.00 |
|
% Held by Insiders
|
0.01 |
|
% Held by Institutions
|
11.00 |
|
Shares Short (K)
|
5730 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
0.990 |
|
EPS Est. Current Year
|
2.890 |
|
EPS Est. Next Year
|
2.850 |
|
EPS Est. Next Quarter
|
|
|
Forward EPS
|
2.930 |
|
Book Value (p.s.)
|
2.410 |
|
PEG Ratio
|
1.60 |
|
Profit Margin
|
12.49 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
8.3 |
|
Return on Equity (ttm)
|
122.7 |
|
Qtrly Rev. Growth
|
6.1 |
|
Gross Profit (p.s.)
|
8.478 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
51.20 |
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
41.57 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
17.08 |
|
P/S
|
|
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
1.060 |
|
Dividend Yield
|
0.03 |
|
Dividend Pay Date
|
2019-07-11 |
|
Ex-Dividend Date
|
2019-05-16 |
|
Forward Dividend
|
1.980 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
